Largest pharmaceutical companies by revenue
Everything the company sold in its latest fiscal year, before any cost is taken off.
Spyre Therapeutics has the lowest figure of the 52 pharmaceutical companies ranked by revenue, at SGD 0, followed by Praxis Precision Medicines (SGD 0) and Dianthus Therapeutics (SGD 2.6M). Figures as of 18 Nov 2026, 22:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 52
- Lowest
- Spyre TherapeuticsSGD 0
- Median
- SGD 4.1B
- Combined market value
- SGD 6.52T
- Countries
- 10
- Not ranked
- 9no revenue on file
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Revenue ↑ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Spyre TherapeuticsSYRE · Health Care | SGD 0 | SGD 12.4B | SGD 130.78 | 8.15% up | 286% up | ||
| 2 | Praxis Precision MedicinesPRAX · Health Care | SGD 0 | SGD 11B | SGD 393.39 | 0.04% up | 61% up | ||
| 3 | Dianthus TherapeuticsDNTH · Health Care | SGD 2.6M | SGD 6.1B | SGD 108.25 | 3.45% down | 113% up | ||
| 4 | Roivant SciencesROIV · Health Care | SGD 10.6M | SGD 36.2B | SGD 49.92 | 0.05% up | 90% up | ||
| 5 | Protagonist TherapeuticsPTGX · Health Care | SGD 59.3M | SGD 10.7B | SGD 163.91 | 2.00% up | 46% up | ||
| 6 | CytokineticsCYTK · Health Care | SGD 113.5M | SGD 9.2B | SGD 66.15 | 0.64% down | 20% down | ||
| 7 | Rhythm PharmaceuticalsRYTM · Health Care | SGD 244.6M | SGD 10.6B | SGD 153.44 | 2.08% up | 13% up | ||
| 8 | Ligand PharmaceuticalsLGND · Health Care | SGD 345.6M | SGD 7.7B | SGD 385.03 | 1.67% up | 43% up | ||
| 9 | Travere TherapeuticsTVTX · Health Care | SGD 632.5M | SGD 6.2B | SGD 64.76 | 1.68% down | 44% up | ||
| 10 | BridgeBio PharmaBBIO · Health Care | SGD 647.2M | SGD 19.6B | SGD 100.55 | 1.58% up | 17% up | ||
| 11 | Mirum PharmaceuticalsMIRM · Health Care | SGD 672M | SGD 7.8B | SGD 119.22 | 0.59% up | 31% up | ||
| 12 | InsmedINSM · Health Care | SGD 781.7M | SGD 33.9B | SGD 154.42 | 1.69% down | 40% down | ||
| 13 | TG TherapeuticsTGTX · Health Care | SGD 794.4M | SGD 12.9B | SGD 85.23 | 5.44% up | 107% up | ||
| 14 | Axsome TherapeuticsAXSM · Health Care | SGD 823M | SGD 9.1B | SGD 172.72 | 1.43% down | 7% down | ||
| 15 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | SGD 873.4M | SGD 9.6B | SGD 122.52 | 0.06% down | 126% up | ||
| 16 | Corcept TherapeuticsCORT · Health Care | SGD 981.4M | SGD 9.6B | SGD 87.38 | 3.25% down | 8% down | ||
| 17 | Ascendis PharmaASND · Health Care | SGD 1B | SGD 22.9B | SGD 348.45 | 0.32% down | 28% up | ||
| 18 | Arrowhead PharmaceuticalsARWR · Health Care | SGD 1.1B | SGD 7.9B | SGD 55.57 | 0.28% up | 10% up | ||
| 19 | Ionis PharmaceuticalsIONS · Health Care | SGD 1.2B | SGD 5.9B | SGD 35.31 | 1.59% up | 64% down | ||
| 20 | Madrigal PharmaceuticalsMDGL · Health Care | SGD 1.2B | SGD 11.9B | SGD 513.12 | 5.67% down | 24% down | ||
| 21 | Legend BiotechLEGN · Health Care | SGD 1.3B | SGD 4.1B | SGD 20.95 | 0.87% up | 42% down | ||
| 22 | AlkermesALKS · Health Care | SGD 1.9B | SGD 10.1B | SGD 60.39 | 3.08% up | 58% up | ||
| 23 | PTC TherapeuticsPTCT · Health Care | SGD 2.2B | SGD 6.5B | SGD 77.64 | 0.22% down | 20% down | ||
| 24 | Royalty PharmaRPRX · Health Care | SGD 3.1B | SGD 50.9B | SGD 88.51 | 0.01% down | 78% up | ||
| 25 | Amneal PharmaceuticalsAMRX · Health Care | SGD 3.9B | SGD 9.8B | SGD 28.20 | 3.60% up | 83% up | ||
| 26 | United TherapeuticsUTHR · Health Care | SGD 4.1B | SGD 31.7B | SGD 744.19 | 1.16% down | 23% up | ||
| 27 | BioMarin PharmaceuticalBMRN · Health Care | SGD 4.2B | SGD 15.3B | SGD 79.18 | 4.99% up | 11% up | ||
| 28 | Dr. Reddy's LaboratoriesRDY · Health Care | SGD 4.6B | SGD 16.1B | SGD 19.31 | 1.28% up | 5% up | ||
| 29 | Alnylam PharmaceuticalsALNY · Health Care | SGD 4.8B | SGD 25.8B | SGD 192.58 | 4.54% down | 66% down | ||
| 30 | GenmabGMAB · Health Care | SGD 4.8B | SGD 40.5B | SGD 65.70 | 1.91% down | 70% up | ||
| 31 | Jazz PharmaceuticalsJAZZ · Health Care | SGD 5.5B | SGD 20.5B | SGD 319.37 | 2.93% up | 37% up | ||
| 32 | Elanco Animal HealthELAN · Health Care | SGD 6.1B | SGD 17.2B | SGD 34.42 | 3.29% up | 20% up | ||
| 33 | BeOne MedicinesONC · Health Care | SGD 6.9B | SGD 59.4B | SGD 520.24 | 2.34% down | 17% up | ||
| 34 | GrifolsGRFS · Health Care | SGD 10.8B | SGD 7.4B | SGD 10.92 | 1.85% down | 1% up | ||
| 35 | ZoetisZTS · Health Care | SGD 12.2B | SGD 44.8B | SGD 110.30 | 2.50% up | 29% down | ||
| 36 | Vertex PharmaceuticalsVRTX · Health Care | SGD 15.5B | SGD 175.3B | SGD 691.48 | 0.42% up | 27% up | ||
| 37 | ViatrisVTRS · Health Care | SGD 18.4B | SGD 30B | SGD 26.14 | 0.83% down | 96% up | ||
| 38 | Regeneron PharmaceuticalsREGN · Health Care | SGD 18.5B | SGD 126.1B | SGD 1,218.78 | 1.28% down | 36% up | ||
| 39 | Teva Pharmaceutical IndustriesTEVA · Health Care | SGD 22.2B | SGD 63.5B | SGD 54.43 | 0.92% down | 74% up | ||
| 40 | Takeda PharmaceuticalTAK · Health Care | SGD 36.4B | SGD 87.6B | SGD 27.42 | 1.71% down | 54% up | ||
| 41 | GSKGSK · Health Care | SGD 55.9B | SGD 125.5B | SGD 62.62 | 1.34% down | 6% up | ||
| 42 | Abbott LaboratoriesABT · Health Care | SGD 57.1B | SGD 233.2B | SGD 134.67 | 0.22% down | 17% down | ||
| 43 | Novo NordiskNVO · Health Care | SGD 59.1B | SGD 224B | SGD 50.82 | 3.12% down | 17% down | ||
| 44 | Bristol-Myers SquibbBMY · Health Care | SGD 62.1B | SGD 156.9B | SGD 76.77 | 2.92% down | 34% up | ||
| 45 | SanofiSNY · Health Care | SGD 62.4B | SGD 145.8B | SGD 60.74 | 0.86% down | 4% down | ||
| 46 | NovartisNVS · Health Care | SGD 70.3B | SGD 377.8B | SGD 200.06 | 2.46% down | 25% up | ||
| 47 | AstraZenecaAZN · Health Care | SGD 75.7B | SGD 357.4B | SGD 230.42 | 1.93% down | 2% up | ||
| 48 | AbbVieABBV · Health Care | SGD 78.8B | SGD 651.7B | SGD 368.66 | 2.33% down | 26% up | ||
| 49 | PfizerPFE · Health Care | SGD 80.7B | SGD 206.2B | SGD 36.17 | 1.44% down | 14% up | ||
| 50 | Merck & CoMRK · Health Care | SGD 83.8B | SGD 437.8B | SGD 177.60 | 3.90% down | 51% up | ||
| 51 | Eli LillyLLY · Health Care | SGD 84B | SGD 1.59T | SGD 1,782.35 | 2.32% down | 35% up | ||
| 52 | Johnson & JohnsonJNJ · Health Care | SGD 121.4B | SGD 846.2B | SGD 351.51 | 2.15% down | 38% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Revenue is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 1.2890 SGD). 9 companies have no revenue on file and are not ranked here.
Questions and answers
Which pharmaceutical companies have the lowest revenue?
Spyre Therapeutics (SGD 0), Praxis Precision Medicines (SGD 0) and Dianthus Therapeutics (SGD 2.6M) have the lowest revenue of the 52 pharmaceutical companies ranked here as of 18 Nov 2026, 22:41 UTC.
How many pharmaceutical companies are in this ranking?
52 are ranked by revenue. 9 more have no revenue on file and are left out rather than ranked at zero.
What are these pharmaceutical companies worth together?
The 52 pharmaceutical companies ranked by revenue have a combined market value of SGD 6.52T as of 18 Nov 2026, 22:41 UTC.
What does ranking by revenue measure?
Everything the company sold in its latest fiscal year, before any cost is taken off.
Learn how this ranking works
All markets guides →- Revenue vs earnings vs free cash flow: what each tells you
Revenue is everything a company sold in a period. Earnings, or net income, is what remains after every cost, interest and tax. Free cash flow is the cash operations brought in minus spending on long-lived assets. Revenue shows size and demand, earnings show profitability, and free cash flow shows how much cash the business can actually hand out.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
- How companies are sorted into sectors and industries
Companies are sorted into sectors and industries by classification systems. The index providers MSCI and S&P Dow Jones Indices use GICS: 11 sectors split into 25 industry groups, 74 industries and 163 sub-industries. SEC filings carry a four-digit SIC code. The two can place one company differently, because each looks at the business from its own angle.
Cite this page
Funkfolio, “Largest pharmaceutical companies by revenue”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=revenue
Underlying data: Yahoo Finance; SEC EDGAR.